鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/15 | 3,270 | 3,335 | 3,260 | 3,335 | +120 | +3.7% | 101,000 |
2020/07/14 | 3,160 | 3,235 | 3,155 | 3,215 | +60 | +1.9% | 59,900 |
2020/07/13 | 3,140 | 3,165 | 3,105 | 3,155 | +55 | +1.8% | 59,500 |
2020/07/10 | 3,140 | 3,170 | 3,100 | 3,100 | +15 | +0.5% | 52,200 |
2020/07/09 | 3,110 | 3,120 | 3,055 | 3,085 | +10 | +0.3% | 52,400 |
2020/07/08 | 3,040 | 3,110 | 3,040 | 3,075 | +35 | +1.2% | 49,700 |
2020/07/07 | 3,055 | 3,060 | 3,010 | 3,040 | +20 | +0.7% | 52,200 |
2020/07/06 | 3,020 | 3,050 | 2,993 | 3,020 | ±0 | ±0% | 36,300 |
2020/07/03 | 3,005 | 3,025 | 2,968 | 3,020 | +52 | +1.8% | 30,900 |
2020/07/02 | 3,060 | 3,060 | 2,945 | 2,968 | -57 | -1.9% | 72,900 |
2020/07/01 | 3,145 | 3,145 | 3,020 | 3,025 | -75 | -2.4% | 52,100 |
2020/06/30 | 3,090 | 3,150 | 3,055 | 3,100 | +70 | +2.3% | 48,400 |
2020/06/29 | 3,095 | 3,095 | 2,976 | 3,030 | -60 | -1.9% | 40,800 |
2020/06/26 | 3,090 | 3,100 | 3,015 | 3,090 | +40 | +1.3% | 39,000 |
2020/06/25 | 3,070 | 3,110 | 3,030 | 3,050 | -15 | -0.5% | 37,500 |
2020/06/24 | 3,130 | 3,135 | 3,060 | 3,065 | +5 | +0.2% | 25,800 |
2020/06/23 | 3,010 | 3,080 | 2,991 | 3,060 | +60 | +2% | 37,200 |
2020/06/22 | 2,995 | 3,025 | 2,941 | 3,000 | +7 | +0.2% | 26,900 |
2020/06/19 | 3,050 | 3,050 | 2,946 | 2,993 | -57 | -1.9% | 118,400 |
2020/06/18 | 3,120 | 3,140 | 3,035 | 3,050 | -35 | -1.1% | 70,400 |
2020/06/17 | 3,185 | 3,205 | 3,075 | 3,085 | -90 | -2.8% | 61,600 |
2020/06/16 | 3,135 | 3,195 | 3,085 | 3,175 | +95 | +3.1% | 104,400 |
2020/06/15 | 3,120 | 3,190 | 3,080 | 3,080 | -25 | -0.8% | 82,500 |
2020/06/12 | 3,070 | 3,135 | 3,060 | 3,105 | -50 | -1.6% | 51,300 |
2020/06/11 | 3,250 | 3,250 | 3,125 | 3,155 | -110 | -3.4% | 34,100 |
2020/06/10 | 3,285 | 3,395 | 3,205 | 3,265 | +45 | +1.4% | 85,000 |
2020/06/09 | 3,150 | 3,230 | 3,115 | 3,220 | +130 | +4.2% | 54,300 |
2020/06/08 | 3,155 | 3,155 | 3,075 | 3,090 | -60 | -1.9% | 32,100 |
2020/06/05 | 3,180 | 3,180 | 3,105 | 3,150 | +5 | +0.2% | 25,600 |
2020/06/04 | 3,195 | 3,195 | 3,105 | 3,145 | -20 | -0.6% | 29,600 |
2020/06/03 | 3,230 | 3,230 | 3,125 | 3,165 | -40 | -1.2% | 40,100 |
2020/06/02 | 3,250 | 3,250 | 3,190 | 3,205 | -15 | -0.5% | 25,500 |
2020/06/01 | 3,295 | 3,295 | 3,185 | 3,220 | -25 | -0.8% | 35,000 |
2020/05/29 | 3,195 | 3,315 | 3,195 | 3,245 | +55 | +1.7% | 75,500 |
2020/05/28 | 3,135 | 3,220 | 3,085 | 3,190 | +110 | +3.6% | 77,200 |
2020/05/27 | 3,000 | 3,110 | 2,966 | 3,080 | +81 | +2.7% | 89,000 |
2020/05/26 | 2,996 | 3,010 | 2,926 | 2,999 | ±0 | ±0% | 63,700 |
2020/05/25 | 2,995 | 3,010 | 2,926 | 2,999 | +28 | +0.9% | 50,100 |
2020/05/22 | 2,998 | 2,998 | 2,928 | 2,971 | -20 | -0.7% | 61,200 |
2020/05/21 | 2,981 | 3,000 | 2,947 | 2,991 | -9 | -0.3% | 93,000 |
2020/05/20 | 2,860 | 3,020 | 2,839 | 3,000 | +156 | +5.5% | 90,500 |
2020/05/19 | 2,899 | 2,906 | 2,817 | 2,844 | -18 | -0.6% | 51,700 |
2020/05/18 | 2,849 | 2,881 | 2,821 | 2,862 | +57 | +2% | 76,800 |
2020/05/15 | 2,847 | 2,847 | 2,777 | 2,805 | -54 | -1.9% | 116,800 |
2020/05/14 | 2,950 | 2,950 | 2,842 | 2,859 | -105 | -3.5% | 110,600 |
2020/05/13 | 2,986 | 3,000 | 2,929 | 2,964 | -76 | -2.5% | 81,700 |
2020/05/12 | 2,990 | 3,085 | 2,970 | 3,040 | +71 | +2.4% | 49,100 |
2020/05/11 | 3,005 | 3,005 | 2,941 | 2,969 | +21 | +0.7% | 42,900 |
2020/05/08 | 3,025 | 3,045 | 2,926 | 2,948 | -38 | -1.3% | 57,400 |
2020/05/07 | 2,986 | 3,035 | 2,943 | 2,986 | +26 | +0.9% | 44,400 |
1251~
1300
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 154,000円 | +5.0% | +1.5% | 0.00% | 13.18倍 | 3.71倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 426,500円 | +3.6% | - | 2.81% | 14.37倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 239,600円 | - | - | 0.00% | - | 110.98倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム